Ponatinib: A Third-Generation Inhibitor for the Treatment of CML
Crossref DOI link: https://doi.org/10.1007/978-3-319-91439-8_5
Published Online: 2018-08-02
Published Print: 2018
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wehrle, Julius
von Bubnoff, Nikolas
License valid from 2018-01-01